8-chloromethyl-3-methylflavone | 152737-40-1

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 黄酮类化合物
• 英文名称: 8-chloromethyl-3-methylflavone
• 英文别名: 8-chloromethyl-3-methyl-4-oxo-2-phenyl-4H-1-benzopyran；8-(chloromethyl)-3-methyl-2-phenylchromen-4-one
• CAS: 152737-40-1
• 化学式: C₁₇H₁₃ClO₂
• 分子量: 284.742
• InChiKey: HORAOKMGKDQDED-UHFFFAOYSA-N

物化性质

• 沸点：
  448.7±45.0 °C(Predicted)
• 密度：
  1.265±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  8-chloromethyl-3-methylflavone 在 sodium 作用下， 以 5,5-dimethyl-1,3-cyclohexadiene 、 水 、 乙二醇 为溶剂， 生成 8-(2-hydroxyethoxymethyl)-3-methyl-4-oxo-2-phenyl-4H-1-benzopyran
  参考文献：
  名称：

  Flavone derivatives

  摘要：

  公开号：

  EP0566288B1
• 作为产物：
  描述：

  8-hydroxymethyl-3-methylflavone 在 氯化亚砜 、 三乙胺 作用下， 以 氯仿 、 水 为溶剂， 生成 8-chloromethyl-3-methylflavone
  参考文献：
  名称：

  Flavone derivatives

  摘要：

  公开号：

  EP0566288B1

文献信息

• Benzopyran and benzothiopyran derivatives
  申请人：Recordati S.A., Chemical and Pharmaceutical Company

  公开号：US05403842A1

  公开（公告）日：1995-04-04

  The invention relates to benzopyranone and benzothiopyranone compounds, compositions and methods of use which have adrenergic and serotonergic activity.

  本发明涉及苯并吡喃酮和苯并噻吩酮化合物，组合物和使用方法，具有肾上腺素能和5-羟色胺能活性。
• Bicyclic heterocyclic derivatives having .alpha..sub.1 adrenergic and
  申请人：Recordati S.A., Chemical and Pharmaceutical Company

  公开号：US05605896A1

  公开（公告）日：1997-02-25

  This invention provides bicyclic heterocyclic derivatives and their pharmaceutically acceptable salts useful for the treatment of hypertension, urethral and lower urinary tract contractions, and other disorders. The compounds are also useful for binding .alpha..sub.1 -adrenergic and 5HT.sub.1A serotonergic receptors, in vitro or in vivo.

  本发明提供了双环杂环衍生物及其药学上可接受的盐，用于治疗高血压、尿道和下泌尿道收缩以及其他疾病。这些化合物还可用于体外或体内结合.alpha..sub.1-肾上腺素能和5HT.sub.1A-5-羟色胺能受体。
• Aromatic amino acid derivates and medicinal compositions
  申请人：Endo Hitoshi

  公开号：US20050119256A1

  公开（公告）日：2005-06-02

  1. An aromatic amino acid derivative represented by the formula (I) or its pharmacologically acceptable salt: wherein, R 1 is a hydrogen atom or an amino-protecting group, R 2 is a halogen atom or an alkyl, aralkyl or aryl group, R 3 is circle over (1)} a hydrogen atom, circle over (2)} an aroylamino group, circle over (3)} a phenyl group substituted with lower alkyl, phenyl, phenoxy, etc. circle over (4)} a naphthyl or tetrahydronaphthyl group optionally substituted with hydroxy, lower alkoxy or di(lower)alkylamino, circle over (5)} an unsaturated mono-cyclic heterocyclic group containing N, O and/or S substituted with lower alkyl, phenyl, naphthyl or tetrahydroquinolyl, circle over (6)} an unsaturated or partially saturated condensed heterocyclic group containing N, O and/or S, optionally substituted with oxo, carboxy, amino, lower alkyl, etc.; X is a halogen atom, an alkyl group or an alkoxy group; Y is oxygen atom or nitrogen atom; I is 0 or 1; m is 0, 1 or 2; n is an integer of 0-5. This compound can inhibit a transporter (LAT1) of essential amino acid which is one of main nutrition for cancer cells and accordingly cause drain of the essential amino acid on the cancer cells and finally can prohibit the multiplication of cancer cells.

  一种芳香族氨基酸衍生物，其化学式为（I）或其药理学上可接受的盐：其中，R1为氢原子或氨基保护基；R2为卤素原子或烷基、芳基烷基或芳基基团；R3为circle over (1)}氢原子，circle over (2)}芳基氨基基团，circle over (3)}苯基，其取代基为较低的烷基、苯基、苯氧基等，circle over (4)}萘基或四氢萘基，可选地取代羟基、较低的烷氧基或二（较低）烷基氨基，circle over (5)}含N、O和/或S的不饱和单环杂环基团，取代基为较低的烷基、苯基、萘基或四氢喹啉基团，circle over (6)}含N、O和/或S的不饱和或部分饱和的紧缩杂环基团，可选地取代为氧代、羧基、氨基、较低的烷基等；X为卤素原子、烷基或烷氧基；Y为氧原子或氮原子；I为0或1；m为0、1或2；n为0-5的整数。该化合物可以抑制癌细胞的主要营养物质之一的必需氨基酸转运体（LAT1），从而导致癌细胞必需氨基酸的流失，最终可以抑制癌细胞的增殖。
• Bicyclic heterocyclic derivatives having .alpha..sub.1 -adrenergic and
  申请人：Recordati S.A., Chemical and Pharmaceutical Company

  公开号：US05474994A1

  公开（公告）日：1995-12-12

  This invention provides bicyclic heterocyclic derivatives and their pharmaceutically acceptable salts useful for the treatment of hypertension, urethral and lower urinary tract contractions, and other disorders. The compounds are also useful for binding .alpha..sub.1 -adrenergic and 5HT.sub.1A serotonergic receptors, in vitro or in vivo.

  本发明提供了双环杂环衍生物及其药学上可接受的盐，用于治疗高血压、尿道和下泌尿道收缩以及其他疾病。该化合物还可用于体外或体内结合α1-肾上腺素能和5HT1A-5-羟色胺能受体。
• Aromatic amino acid derivatives and medicinal compositions
  申请人：——

  公开号：US07345068B2

  公开（公告）日：2008-03-18

  1. An aromatic amino acid derivative represented by the formula (I) or its pharmacologically acceptable salt: wherein, R1 is a hydrogen atom or an amino-protecting group, R2 is a halogen atom or an alkyl, aralkyl or aryl group, R3 is circle around (1)} a hydrogen atom, circle around (2)} an aroylamino group, circle around (3)} a phenyl group substituted with lower alkyl, phenyl, phenoxy, etc. circle around (4)} a naphthyl or tetrahydronaphthyl group optionally substituted with hydroxy, lower alkoxy or di(lower)alkylamino, circle around (5)} an unsaturated mono-cyclic heterocyclic group containing N, O and/or S substituted with lower alkyl, phenyl, naphthyl or tetrahydroquinolyl, circle around (6)} an unsaturated or partially saturated condensed heterocyclic group containing N, O and/or S, optionally substituted with oxo, carboxy, amino, lower alkyl, etc.; X is a halogen atom, an alkyl group or an alkoxy group; Y is oxygen atom or nitrogen atom; l is 0 or 1; m is 0, 1 or 2; n is an integer of 0-5. This compound can inhibit a transporter (LAT1) of essential amino acid which is one of main nutrition for cancer cells and accordingly cause drain of the essential amino acid on the cancer cells and finally can prohibit the multiplication of cancer cells.

  一种芳香族氨基酸衍生物，其化学式为（I）或其药学上可接受的盐：其中，R1是氢原子或氨基保护基，R2是卤素原子或烷基、芳基烷基或芳基基团，R3是圆圈1}氢原子，圆圈2}芳酰氨基基团，圆圈3}苯基取代较低烷基、苯基、苯氧基等的基团，圆圈4}萘基或四氢萘基基团，可选地取代羟基、较低烷氧基或二（较低）烷基氨基，圆圈5}含有N、O和/或S的不饱和单环杂环基团，取代较低烷基、苯基、萘基或四氢喹啉基团，圆圈6}含有N、O和/或S的不饱和或部分饱和的紧缩杂环基团，可选地取代氧代、羧基、氨基、较低烷基等；X是卤素原子、烷基或烷氧基；Y是氧原子或氮原子；l为0或1；m为0、1或2；n为0-5的整数。该化合物可以抑制癌细胞的主要营养物质之一的必需氨基酸的转运体（LAT1），从而导致癌细胞中必需氨基酸的流失，最终可以抑制癌细胞的增殖。